Home > Insider Trading > Filing (0001181431-14-038645)

Filing Details

Accession Number:: 0001181431-14-038645
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-12-11 16:49:01
Reporting Period:: 2014-12-09

Filing Date:: 2014-12-11
Accepted Time:: 2014-12-11 16:49:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1407038	Bg Medicine Inc.	BGMD	In Vitro & In Vivo Diagnostic Substances (2835)	043506204

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1255927	Jr M Edwin Kania	C/O Flagship Ventures One Memorial Drive, 7Th Floor Cambridge MA 02142		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-12-09	6,301	$0.36	23,940	No	4	S	Indirect	Held by OneLiberty Advisors Fund IV, L.P.
Common Stock	Disposition	2014-12-10	5,472	$0.32	18,468	No	4	S	Indirect	Held by OneLiberty Advisors Fund IV, L.P.
Common Stock	Disposition	2014-12-11	18,468	$0.30	0	No	4	S	Indirect	Held by OneLiberty Advisors Fund IV, L.P.
Common Stock	Disposition	2014-12-09	125,789	$0.36	478,360	No	4	S	Indirect	Held by OneLiberty Fund IV, L.P.
Common Stock	Disposition	2014-12-10	109,248	$0.32	369,112	No	4	S	Indirect	Held by OneLiberty Fund IV, L.P.
Common Stock	Disposition	2014-12-11	369,112	$0.30	0	No	4	S	Indirect	Held by OneLiberty Fund IV, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Held by OneLiberty Advisors Fund IV, L.P.
No	4	S	Indirect	Held by OneLiberty Advisors Fund IV, L.P.
No	4	S	Indirect	Held by OneLiberty Advisors Fund IV, L.P.
No	4	S	Indirect	Held by OneLiberty Fund IV, L.P.
No	4	S	Indirect	Held by OneLiberty Fund IV, L.P.
No	4	S	Indirect	Held by OneLiberty Fund IV, L.P.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	215,013	Indirect	Held by AGTC Advisors Fund, L.P.
Common Stock	2,851,447	Indirect	Held by Applied Genomic Technology Capital Fund, L.P.
Common Stock	1,764,286	Indirect	Held by Flagship Ventures Fund 2007, L.P.
Common Stock	4,232	Indirect	Held by OneLiberty Advisors Fund 2000 L.P.
Common Stock	80,424	Indirect	Held by OneLiberty Ventures 2000 L.P.

Footnotes

Edwin M. Kania, Jr. is a managing member of OneLiberty Partners IV LLC, which is the general partner of OneLiberty Advisors IV, L.P. ("OLA IV") and OneLiberty Fund IV, L.P. ("OLF IV"), and may be deemed to beneficially own the securities held by OLA IV and OLF IV. Mr. Kania disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
NewcoGen Group, Inc. ("NG") is the general partner of AGTC Partners, L.P., which is the general partner of AGTC Advisors Fund, L.P. ("AGTCA") and Applied Genomic Technology Capital Fund L.P. ("AGTCF", and together with AGTCA, the "AGTC Funds"). NG is a wholly-owned subsidiary of Flagship Ventures Management, Inc. ("Flagship"). Edwin M. Kania, Jr. is a director of Flagship and may be deemed to beneficially own the securities held by the AGTC Funds. Mr. Kania disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
Edwin M. Kania, Jr. is a manager of Flagship Ventures 2007 General Partner, LLC, which is the general partner of Flagship Ventures Fund 2007, L.P., and may be deemed to beneficially own the securities held by Flagship Ventures Fund 2007, L.P. Mr. Kania disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
Edwin M. Kania, Jr. is a managing member of OneLiberty Partners 2000, LLC, which is the general partner of OneLiberty Advisors Fund 2000 L.P. ("OLA") and OneLiberty Ventures 2000 L.P. ("OLV"), and may be deemed to beneficially own the securities held by OLA and OLV. Mr. Kania disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.